Tim-brim-dor-lat
Product Images NDC 70261-522

2 FDA label images from Imprimisrx Nj · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tim-brim-dor-lat (NDC 70261-522). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Imprimisrx Nj, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6ba41645 1dc6 5b0f E053 2991aa0a498e

6ba41645 1dc6 5b0f E053 2991aa0a498e
Label for Timolol-Brimonidine-Dorzolamide-Latanoprost ophthalmic drops in a sterile 5ml bottle by ImprimisRx NJ. The label displays the combined concentrations as (0.5/0.15/2/0.005)% and includes detailed ingredient information, storage instructions, and a barcode. It states the product is for licensed professional or patient use only.*
FDA Label Image

Bottle Label (Timbrimdorlat)

Bottle Label (Timbrimdorlat)
Label for Timolol-Brimonidine-Dorzolamide-Latanoprost ophthalmic drops in a sterile 5 ml bottle by ImprimisRx NJ. The label displays the combined active ingredient percentages (0.5/0.15/2/0.005)%, NDC 70261-522-05, and storage instructions. It includes manufacturer contact details and instructions that the product is Rx only and compounded for professional or patient use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.